Clinical Trials on Multiple Endocrine Neoplasia Type II
Total 60117 results
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
PfizerCompletedDiabetes Mellitus, Type IIUnited States
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research InstituteUnknownMeasuring the Priorities of Patients With Type II Diabetes Using Likert Scale and Best-worst ScalingType II DiabetesUnited States
-
Medical University of ViennaCompletedDiabetes Mellitus Type IIAustria
-
BayerCompleted
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and DevelopmentUnknown
-
Arizona State UniversityTakeda Pharmaceuticals North America, Inc.UnknownType II Diabetes MellitusUnited States
-
AstraZenecaCompletedType II Diabetes MellitusUnited States
-
Ferzli, George S., M.D. F.A.C.S.UnknownType II DiabetesUnited States
-
AstraZenecaParexelTerminatedType II Diabetes MellitusUnited Kingdom
-
Centre Hospitalier Universitaire, AmiensMerck Serono International SACompletedRenal Disorder Associated With Type II Diabetes MellitusFrance
-
National Institute of Diabetes and Digestive and...CompletedDiabetes Mellitus, Type IIUnited States
-
Mike O'Callaghan Military HospitalCompletedType II Diabetes MellitusUnited States
-
Washington University School of MedicineCompletedDiabetes Mellitus, Type IIUnited States
-
Hoffmann-La RocheRoche Diabetes Care Deutschland GmbHCompleted
-
Walter Reed National Military Medical CenterCompletedType II Diabetes MellitusUnited States
-
Astellas Pharma IncAjinomoto USA, INC.CompletedType 2 Diabetes Mellitus | Diabetes Mellitus, Type IIJapan
-
University of BolognaCompletedSiewert Type I-II Adenocarcinoma of the EsophagusItaly
-
Medical University of South CarolinaCompleted
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Tehran University of Medical SciencesUnknown
-
EMSNot yet recruitingType 2 Diabetes MellitusBrazil
-
Basque Culinary Center FundazioaUniversity of NavarraCompletedType 2 Diabetes MellitusSpain
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.UnknownDiabetes Mellitus, Type II
-
Duke UniversityCompleted
-
Ageless Regenerative InstituteWithdrawnDiabetes Mellitus Type IIUnited States
-
Zhongda HospitalUnknownType II Diabetes MellitusChina
-
Northwestern UniversityUniversity of North CarolinaWithdrawnDiabetes Mellitus, Type II
-
CellMed AG, a subsidiary of BTG plc.Completed
-
AstraZenecaCompleted
-
University of JaénCompletedAdult ALL | Diabete Type 2Spain
-
Neurotronic, Inc.WithdrawnObesity | Type2 Diabetes Mellitus
-
Spanish National Research CouncilAndalusian Health Service; Universidad Pablo de OlavideRecruitingType II Diabetes Mellitus | Diabetic PatientsSpain
-
University of LahoreRecruitingPatient CompliancePakistan
-
Sultan Qaboos UniversityKarolinska Institutet; Nova BiomedicalRecruitingType 2 Diabetes | Magnesium DisorderOman
-
Japan Tobacco Inc.CompletedType II HyperlipidaemiaNetherlands
-
Taipei Medical University WanFang HospitalHi-Q Marine Biotech International, Ltd.Unknown
-
Supreme Council Of Health, QatarUnknownInsulin ResistanceQatar
-
National Cancer Institute (NCI)CompletedLung Carcinoid Tumor | Metastatic Digestive System Neuroendocrine Tumor G1 | Pancreatic Polypeptide Tumor | Multiple Endocrine Neoplasia Type 1 | Pancreatic Glucagonoma | Pancreatic Insulinoma | Somatostatin-Producing Neuroendocrine Tumor | Recurrent Digestive System Neuroendocrine Tumor G1 | Recurrent... and other conditionsUnited States
-
University of California, San FranciscoCompletedDiabetes Type IIUnited States
-
Regional Hospital HolstebroMedical ResearchCompletedHealthy SubjectsDenmark
-
Gruppo Italiano per lo studio dei Carcinomi dell...Unità Sperimentazioni cliniche; Istituto Nazionale Tumori di NapoliCompletedPancreatic Cancer Stage IIItaly
-
Centre Hospitalier Sud FrancilienCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedInsulin Resistance | Diabetes Mellitus, Type IIUnited States
-
Health Education Research Foundation (HERF)Not yet recruitingType II Diabetes Mellitus With Neurological Manifestations
-
Margarida Magalhaes-SilvermanNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Primary Systemic Amyloidosis | Light Chain Deposition Disease | Extramedullary Plasmacytoma | Isolated Plasmacytoma of BoneUnited States
-
SanofiTerminatedType II Diabetes Mellitus